DEMOCRATIC CONVENTION: Live Blog  | Keller @ Large | Watch Live Coverage
Genzyme Sold To Sanofi-Aventis In $20 Billion DealCambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.

More From CBS Boston

Summer of Savings
Download Weather App

Listen Live